THE CONAFAY GROUP, LLC

Lobbying for CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP · Representing the voice of emerging antibiotics industry

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY26 Appropriations and PAHPA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.